Calidi Biotherapeutics, Inc.
CLDI
$1.59
$0.053.25%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.41% | -46.02% | 96.53% | -50.01% | 10.11% |
| Total Receivables | -- | -- | -- | 0.00% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 14.69% | 9.61% | 2.12% | -36.74% | 54.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.71% | -12.69% | -21.87% | 21.63% | 13.25% |
| Total Current Assets | 17.54% | -43.27% | 82.31% | -47.35% | 12.34% |
|
|
|||||
| Total Current Assets | 17.54% | -43.27% | 82.31% | -47.35% | 12.34% |
| Net Property, Plant & Equipment | -14.74% | -13.91% | -12.29% | -4.93% | -9.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -1.43% | 250.00% | -72.22% | -5.26% |
| Total Assets | 8.29% | -36.87% | 50.03% | -37.92% | 6.22% |
|
|
|||||
| Total Accounts Payable | 46.82% | -46.60% | -6.44% | 1.83% | -41.90% |
| Total Accrued Expenses | -20.71% | -16.93% | 12.41% | 9.39% | -40.59% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.79% | -18.97% | -14.64% | -10.64% | -38.24% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -2.52% | -24.22% | -2.99% | -1.35% | -42.86% |
|
|
|||||
| Total Current Liabilities | -2.52% | -24.22% | -2.99% | -1.35% | -42.86% |
| Long-Term Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -65.85% | -46.48% | -31.34% | -26.21% | -16.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -41.74% | -42.79% | 95.15% | 18.39% | -32.03% |
| Total Liabilities | -8.67% | -25.37% | -6.10% | -6.31% | -36.43% |
|
|
|||||
| Common Stock & APIC | 3.64% | 0.62% | 7.68% | 0.39% | 8.43% |
| Retained Earnings | -2.90% | -2.95% | -3.89% | -4.51% | -4.10% |
| Treasury Stock & Other | -69.23% | 0.00% | 0.00% | 50.00% | 7.14% |
| Total Common Equity | 31.28% | -45.66% | 292.18% | -74.59% | 352.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.28% | -45.66% | 292.18% | -74.59% | 352.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -10.26% | -12.85% | -17.51% |
| Total Equity | 31.28% | -47.78% | 246.72% | -71.56% | 270.88% |
|
|
|||||